pharma · Recurrent Respiratory Tract Infections · Actinic Keratosis on the Face or Scalp
ALMIRALL S.P.A
Almirall, S.A.
ALMIRALL S.P.A trial registry — 11 ClinicalTrials.gov studies with program phase, status, and indication context.
VIA MESSINA 38, MILANO, Mi 20154, IT, Barcelona HQ
2 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- VIA MESSINA 38, MILANO, Mi 20154, IT, Barcelona
- Employees
- 2
- Programs
- 11
- Drugs
- 20
- Patents
- 308
ALMIRALL S.P.A clinical trials
Registry index of 11 ClinicalTrials.gov studies linked to ALMIRALL S.P.A programs — each row shows trial ID, program name, phase, status, and indication.
ALMIRALL S.P.A trial registry — 11 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for ALMIRALL S.P.A.
-
M-27501-30 — Phase 3
Clinical update -
M-17923-34 — Phase 3
Clinical update -
M-14867-33 — Phase 3
Clinical update -
M-27312-01 — Phase 1
Clinical update -
M-27134-10 — Phase 2
Clinical update -
Klisyri 10 mg/g ointment, Solaraze 30 mg/g Gel — Approved
Clinical update -
LAD328, SODIUM CHLORIDE — Phase 2
Clinical update -
Placebo for LAD603, LAD603 — Phase 2
Clinical update